Cargando…

The value of local consolidative therapy in Osimertinib-treated non-small cell lung cancer with oligo-residual disease

BACKGROUND: There was no study investigating real-world utilization and outcome of LCT in Osimertinib-treated NSCLC with oligo-residual disease. This study was to analyze the clinical value of local consolidative therapy (LCT) in Osimertinib-treated non-small cell lung cancer (NSCLC) patients with o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zeng, Ya, Ni, Jianjiao, Yu, Fan, Zhou, Yue, Zhao, Yang, Li, Shuyan, Guo, Tiantian, Chu, Li, Yang, Xi, Chu, Xiao, Cai, Xuwei, Zhu, Zhengfei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7457298/ https://www.ncbi.nlm.nih.gov/pubmed/32854745 http://dx.doi.org/10.1186/s13014-020-01651-y

Ejemplares similares

Rationale and value of consolidative cranial local therapy in EGFR-mutant non-small cell lung cancer patients with baseline brain metastasis treated with first-line EGFR-TKIs
por: Zeng, Ya, et al.
Publicado: (2023)

Pattern of failure and clinical value of local therapy for oligo‐recurrence in locally advanced non‐small cell lung cancer after definitive chemoradiation: Impact of driver mutation status
por: Zhang, Jinmeng, et al.
Publicado: (2022)

A narrative review of synergistic drug administration in unresectable locally advanced non-small cell lung cancer: current landscape and future prospects in the era of immunotherapy
por: Li, Shuyan, et al.
Publicado: (2020)

Clinical outcomes of advanced non-small cell lung cancer patients harboring distinct subtypes of EGFR mutations and receiving first-line tyrosine kinase inhibitors: brain metastasis and de novo T790M matters
por: Zeng, Ya, et al.
Publicado: (2022)

Radiotherapy for unresectable locally advanced non-small cell lung cancer: a narrative review of the current landscape and future prospects in the era of immunotherapy
por: Guo, Tiantian, et al.
Publicado: (2020)

Identification of lncRNA, MicroRNA, and mRNA-Associated CeRNA Network of Radiation-Induced Lung Injury in a Mice Model
por: Li, Yida, et al.
Publicado: (2019)

A narrative review of evolving roles of radiotherapy in advanced non-small cell lung cancer: from palliative care to active player
por: Zhou, Yue, et al.
Publicado: (2020)

LncRNA-RP11 Modulates TGF-β1-Activated Radiation-Induced Lung Injury Through Downregulating microRNA-29a
por: Yang, Xi, et al.
Publicado: (2020)

Identification and Integrated Analysis of circRNA and miRNA of Radiation-Induced Lung Injury in a Mouse Model
por: Li, Yida, et al.
Publicado: (2021)

Outcomes for Surgery in Stage IA Large Cell Lung Neuroendocrine Compared With Other Types of Non-Small Cell Lung Cancer: A Propensity Score Matching Study Based on the Surveillance, Epidemiology, and End Results (SEER) Database
por: Zou, Liqing, et al.
Publicado: (2020)

Low‐ dose Apatinib promotes vascular normalization and hypoxia reduction and sensitizes radiotherapy in lung cancer
por: Jiang, Shanshan, et al.
Publicado: (2022)

Patterns of brain metastasis immediately before prophylactic cranial irradiation (PCI): implications for PCI optimization in limited-stage small cell lung cancer
por: Chu, Xiao, et al.
Publicado: (2019)

Is clinical target volume necessary?—a failure pattern analysis in patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy using intensity-modulated radiotherapy technique
por: Zou, Liqing, et al.
Publicado: (2020)

Atypical Response in Metastatic Non-Small Cell Lung Cancer Treated with PD-1/PD-L1 Inhibitors: Radiographic Patterns and Clinical Value of Local Therapy
por: Jiang, Shanshan, et al.
Publicado: (2022)

A “Seed-and-Soil” Radiomics Model Predicts Brain Metastasis Development in Lung Cancer: Implications for Risk-Stratified Prophylactic Cranial Irradiation
por: Chu, Xiao, et al.
Publicado: (2023)

Optimal timing and clinical value of radiotherapy in advanced ALK-rearranged non-small cell lung cancer with or without baseline brain metastases: implications from pattern of failure analyses
por: Ni, Jianjiao, et al.
Publicado: (2019)

Recommendation for the definition of postoperative radiotherapy target volume based on a pooled analysis of patterns of failure after radical surgery among patients with thoracic esophageal squamous cell carcinoma
por: Zhang, Xiaofei, et al.
Publicado: (2018)

The efficacy of thoracic radiotherapy in extensive stage small cell lung cancer with baseline brain metastases: a multi-institutional retrospective cohort study
por: Zheng, Zhiqin, et al.
Publicado: (2023)

Regulatory T Cells: An Emerging Player in Radiation-Induced Lung Injury
por: Guo, Tiantian, et al.
Publicado: (2020)

Brain metastases, patterns of intracranial progression, and the clinical value of upfront cranial radiotherapy in patients with metastatic non-small cell lung cancer treated with PD-1/PD-L1 inhibitors
por: Guo, Tiantian, et al.
Publicado: (2022)

Is Performance of Fluorine-18-fluorodeoxyglucose Positron Emission Tomography/Computed tomography (CT) or Contrast-enhanced CT Efficient Enough to Guide the Hilar Lymph Node Staging for Patients with Esophageal Squamous Cell Carcinoma?
por: Chu, Li, et al.
Publicado: (2022)

STING signaling activation modulates macrophage polarization via CCL2 in radiation-induced lung injury
por: Ni, Jianjiao, et al.
Publicado: (2023)

Radiographic Features of Metastatic Brain Tumors from ALK-rearranged Non-small Cell Lung Cancer: Implications for Optimal Treatment Modalities
por: Chu, Li, et al.
Publicado: (2019)

Liquid‐based cell suspension of supraclavicular lymph node fine‐needle aspirate as an alternative specimen for NGS‐based genomic profiling in advanced lung cancer
por: Zhang, Xun, et al.
Publicado: (2020)

Sintilimab, stereotactic body radiotherapy and granulocyte–macrophage colony stimulating factor as second-line therapy for advanced non-small cell lung cancer: safety run-in results of a multicenter, single-arm, phase II trial
por: Ni, Jianjiao, et al.
Publicado: (2021)

The prognostic value of longitudinal circulating tumor DNA profiling during osimertinib treatment
por: Ma, Shenglin, et al.
Publicado: (2021)

The Prognostic Value of Oligo-Recurrence Following Esophagectomy for Esophageal Cancer
por: Kang, Minsang, et al.
Publicado: (2023)

OligoTRAFTACs: A generalizable method for transcription factor degradation
por: Samarasinghe, Kusal T. G., et al.
Publicado: (2022)

Commentary: The Prognostic Value of Oligo-Recurrence Following Esophagectomy for Esophageal Cancer
por: Mine, Shinji
Publicado: (2023)

Synergistic augmentation of osimertinib‐induced autophagic death by proguanil or rapamycin in bladder cancer
por: Xiao, Di, et al.
Publicado: (2023)

TAPO in first‐line osimertinib therapy and continuation of osimertinib
por: Mimura, Chihiro, et al.
Publicado: (2022)

Examination of the effectiveness of local therapy for oligo‐recurrence of EGFR‐mutated NSCLC
por: Sonoda, Dai, et al.
Publicado: (2023)

Oligo-FISH of Populus simonii Pachytene Chromosomes Improves Karyotyping and Genome Assembly
por: Zhao, Yilian, et al.
Publicado: (2023)

Efficacy and safety of osimertinib for leptomeningeal metastases from EGFR-mutant non-small cell lung cancer: a pooled analysis
por: Wen, Lei, et al.
Publicado: (2023)

Mixed response to osimertinib and the beneficial effects of additional local therapy
por: Shinno, Yuki, et al.
Publicado: (2019)

Chromosomal Characterization of Tripidium arundinaceum Revealed by Oligo-FISH
por: Yu, Fan, et al.
Publicado: (2021)

Consolidative Chemoradiotherapy After Induced Chemotherapy Is an Optimal Regimen for Locally Advanced Pancreatic Cancer
por: Wu, Lili, et al.
Publicado: (2020)

OligoRAP – an Oligo Re-Annotation Pipeline to improve annotation and estimate target specificity
por: Neerincx, Pieter BT, et al.
Publicado: (2009)

Polar tagging in the synthesis of monodisperse oligo(p-phenyleneethynylene)s and an update on the synthesis of oligoPPEs
por: Sahoo, Dhananjaya, et al.
Publicado: (2010)

Dosimetric comparison in sparing normal tissue dosage by using auto-SBRT planning in oligo liver tumors
por: Zhang, Shu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_qeg5omnsi8pmur9du56uuovaii